HLA-C and cancer: As shown in Figure 1, adaptive anti-cancer immune responses are triggered by endogenous tumor-associated antigens (TAA) presented to T lymphocytes via the major histocompatibility complex (MHC) context by DCs (reviewed in (51, 53).